Annovis Bio Inc
ANVS
Get informed when a big investor buys or sells
+ FollowMarket Cap$37.77M
Close$
$0.95
48.6% downside
Current Fair Value
48.6% downsideOvervalued by 48.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $37.77 Million |
|---|---|
| Enterprise Value | $-14,181,307,659.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.4 |
| Beta | 1.26 |
| Outstanding Shares | 27,848,000 |
Return
| Return on Equity | -796.05% |
|---|---|
| Return on Assets | -153.20% |
| Return on Invested Capital | -210.79% |
Valuation & Multiples
| P/E Ratio | -1.31 |
|---|---|
| PEG | -0.6 |
| Price to Sales | - |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 1.95 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 18, 2026
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5893▲ 14.94% |
|---|---|
| Total Calls | 329,900▼ 27.65% |
| Total Puts | 194,400▼ 3.09% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 19.03%▼ 2.50% |
|---|---|
| Total Invested | $10.53M▼ 28.21% |
| Investors Holding | 62▲ 3.00% |
ESG Score
No data
About Annovis Bio Inc
CEO: Maria Maccecchini